Loading...
Loading...
Analysts at Bank of America downgraded Seattle Genetics
SGEN from Neutral to Underperform.
The target price for Seattle Genetics has been lowered from $ $40 to $34.
Seattle Genetics shares have dropped 14.48% over the past 52 weeks, while the S&P 500 index has jumped 16.68% in the same period.
Seattle Genetics' shares dropped 2.27% to $37.52 in pre-market trading.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in